Loading company
Drugs Made In America Acquisition II Corp.
DMII · Nasdaq · ·
$10.16+0.1%Sep 25 close
- 1M
- +0.2%
- 6M
- +1.8%
DMII · Nasdaq · ·
$10.16+0.1%Sep 25 close
The quarter ending June 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toJun 30, 2026 | 3 months toJun 30, 2025 | Change |
|---|---|---|---|
| Profit | $4.4M | -$38.1K | +11,647.44% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Drugs Made In America Acquisition II Corp. has no earnings call transcript available.